▁Chron 9.2890625
ic 0.54736328125
▁pain 2.765625
▁is 1.1640625
▁still 6.71875
▁considered 3.990234375
▁to 1.9228515625
▁be 0.03277587890625
▁an 2.6796875
▁extreme 7.265625
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.156005859375
▁ 0.390380859375
8 3.474609375
% 2.189453125
▁of 0.12237548828125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.32080078125
▁countries 0.91796875
. 0.63671875
▁The 2.119140625
▁introduction 7.75390625
▁of 0.0309906005859375
▁the 2.359375
▁study 7.3203125
▁desc 13.921875
rie 8.1953125
bs 3.119140625
▁the 0.51953125
▁apparent 9.4609375
▁link 4.265625
▁between 0.293701171875
▁pain 3.267578125
▁and 0.44140625
▁dem 7.171875
oral 3.625
ization 0.20263671875
. 1.091796875
▁Chron 4.82421875
ic 0.005214691162109375
▁pain 0.133544921875
▁is 1.0986328125
▁always 5.66796875
▁accompanied 2.91015625
▁by 0.28369140625
▁negative 4.10546875
▁emot 0.95703125
ional 1.3740234375
▁experiences 3.09765625
▁and 2.083984375
▁blocks 11.6328125
▁a 3.427734375
▁person 0.8896484375
’ 1.033203125
s 0.00411224365234375
▁ability 1.4169921875
▁to 0.05169677734375
▁receive 6.98828125
▁joy 3.869140625
▁and 1.3681640625
▁satisfaction 3.337890625
▁from 0.89111328125
▁life 0.82568359375
. 0.2418212890625
▁The 1.8212890625
▁research 2.9296875
▁investig 5.29296875
ates 0.373046875
▁the 0.412109375
▁development 6.3046875
▁of 0.1480712890625
▁de 3.513671875
pression 0.422119140625
▁and 1.2861328125
▁anx 1.9638671875
iety 0.003353118896484375
▁among 1.6806640625
▁patients 1.5361328125
▁receiving 6.13671875
▁ph 5.5390625
arma 3.150390625
ce 0.0185546875
ut 0.0013475418090820312
ical 0.009765625
▁op 4.80078125
io 0.1307373046875
ids 0.47509765625
▁and 2.416015625
▁medical 4.3046875
▁am 7.50390625
ri 12.2109375
ju 8.109375
ana 0.06787109375
▁( 3.623046875
MM 3.634765625
) 4.296875
▁as 2.388671875
▁severe 10.0703125
▁pain 0.91943359375
kill 3.150390625
ers 0.0034427642822265625
. 0.267333984375
▁It 3.158203125
▁comp 5.578125
ares 0.01425933837890625
▁the 0.6083984375
▁effic 4.73046875
acy 0.01308441162109375
▁of 0.177001953125
▁pres 6.375
cri 2.017578125
ptions 1.4453125
▁and 1.8037109375
▁exam 5.29296875
ines 0.0273895263671875
▁the 0.4619140625
▁possibility 3.916015625
▁of 0.160888671875
▁post 7.75390625
- 0.6826171875
tre 2.0625
at 0.00429534912109375
ment 0.0094146728515625
▁der 9.625
p 6.8515625
ession 0.2244873046875
. 1.2421875
<0x0A> 0.79638671875
There 4.6171875
▁is 1.3291015625
▁currently 5.8515625
▁a 1.1201171875
▁severe 5.0234375
▁lack 1.9326171875
▁of 0.02252197265625
▁information 2.220703125
▁about 1.1806640625
▁the 0.43017578125
▁effects 3.337890625
▁of 0.08343505859375
▁op 2.5078125
i 3.109375
ates 0.0701904296875
. 3.37890625
▁They 4.50390625
▁manage 8.3515625
▁pain 3.73828125
▁successfully 6.25
, 0.8740234375
▁but 0.240478515625
▁the 2.607421875
▁past 9.15625
▁few 2.30859375
▁dec 1.3525390625
ades 0.003299713134765625
▁indicated 7.21875
▁the 1.78125
▁growing 3.87890625
▁concern 3.423828125
▁regarding 2.96875
▁op 2.83203125
iate 1.015625
▁ab 1.654296875
use 0.0245513916015625
▁in 3.765625
▁forms 8.796875
▁of 0.1761474609375
▁over 3.580078125
d 0.141357421875
ose 0.371826171875
▁and 0.6923828125
▁add 0.75634765625
iction 0.017120361328125
. 0.12744140625
▁A 3.927734375
▁more 4.88671875
▁manage 8.484375
able 0.0088043212890625
▁and 2.158203125
▁sa 2.296875
fer 0.00426483154296875
▁alternative 1.615234375
▁might 5.2421875
▁be 0.150634765625
▁medical 1.1962890625
▁mar 0.53662109375
iju 0.018157958984375
ana 0.00362396240234375
. 0.92724609375
▁However 3.681640625
, 0.015380859375
▁the 1.6552734375
▁legal 4.0703125
▁status 1.115234375
▁and 3.125
▁novel 10.0234375
ty 0.1212158203125
▁of 0.14453125
▁this 2.134765625
▁drug 1.6552734375
▁do 4.3984375
▁not 0.01953125
▁allow 0.68798828125
▁finding 7.1875
▁a 2.357421875
▁large 2.646484375
▁number 0.79931640625
▁of 0.005138397216796875
▁studies 1.3486328125
▁on 1.8037109375
▁its 0.82568359375
▁effect 2.236328125
iveness 0.199951171875
. 0.62646484375
▁Specifically 9.0390625
, 0.07940673828125
▁it 2.56640625
▁concerns 5.1328125
▁the 0.7880859375
▁emot 6.55078125
ional 0.02557373046875
▁condition 4.62109375
▁of 0.2373046875
▁patients 0.7099609375
▁experien 5.25
cing 0.00162506103515625
▁chron 0.83056640625
ic 0.00276947021484375
▁pain 0.05523681640625
. 0.40380859375
▁This 3.130859375
▁research 2.048828125
▁paper 3.94921875
▁a 1.9462890625
ims 0.0007066726684570312
▁to 0.162353515625
▁analyze 3.4765625
▁levels 9.7734375
▁of 0.0225372314453125
▁de 0.53076171875
pression 0.029205322265625
▁and 0.2001953125
▁anx 0.033905029296875
iety 0.003047943115234375
▁among 0.794921875
▁people 2.4765625
▁receiving 2.283203125
▁ther 6.2578125
apy 0.071044921875
▁by 4.6875
▁comparing 8.7578125
▁the 1.568359375
▁effects 2.19921875
▁of 0.0295562744140625
▁ph 2.876953125
arma 0.06011962890625
ce 0.007904052734375
ut 0.0011243820190429688
ical 0.0087432861328125
▁op 0.15185546875
io 0.71337890625
ids 0.033355712890625
▁and 0.25048828125
▁MM 0.5673828125
. 0.2344970703125
<0x0A> 0.431396484375
The 0.8466796875
▁study 1.6142578125
▁was 2.0703125
▁conducted 0.6142578125
▁in 1.2099609375
▁the 1.4697265625
▁form 2.646484375
▁of 0.003570556640625
▁collection 11.3359375
▁and 0.732421875
▁analysis 0.396484375
▁of 0.012359619140625
▁statistical 3.650390625
▁data 0.11431884765625
. 0.90234375
▁Part 4.9921875
icip 0.1846923828125
ants 0.0728759765625
▁were 0.669921875
▁rec 3.40625
ru 0.00559234619140625
ited 0.002529144287109375
▁for 4.1328125
▁six 6.80859375
▁months 0.470947265625
▁at 3.833984375
▁two 2.60546875
▁major 3.880859375
▁pain 2.654296875
▁relief 4.01171875
▁cent 0.78662109375
ers 0.0826416015625
▁in 0.69580078125
▁Israel 5.75
. 0.32373046875
▁The 1.248046875
▁research 2.53125
ers 1.4140625
▁used 2.193359375
▁The 7.05078125
▁De 2.912109375
pression 0.042724609375
▁Module 6.578125
▁of 0.734375
▁the 0.224365234375
▁Pat 3.50390625
ient 0.01366424560546875
▁Health 0.043121337890625
▁Question 0.02410888671875
naire 0.054443359375
▁and 2.76171875
▁the 0.810546875
▁General 1.3173828125
ized 0.6787109375
▁An 0.00759124755859375
x 0.001331329345703125
iety 0.0015516281127929688
▁Dis 0.19189453125
order 0.022247314453125
▁Sc 1.3720703125
ale 0.0033092498779296875
▁to 0.92138671875
▁interview 7.62109375
▁participants 2.779296875
, 4.3125
▁evaluate 4.5078125
▁their 0.517578125
▁answers 4.28125
, 0.452392578125
▁and 0.039703369140625
▁conduct 5.03125
▁the 1.8671875
▁study 2.525390625
. 0.10064697265625
▁To 4.765625
▁specifically 9.8359375
▁evaluate 3.265625
▁and 5.13671875
▁compare 0.56298828125
▁the 0.3740234375
▁prob 9.8984375
abilities 0.1912841796875
▁of 0.0728759765625
▁de 0.8115234375
pression 0.0360107421875
▁or 4.34375
▁anx 0.051055908203125
iety 0.0021724700927734375
▁among 1.41015625
▁the 2.099609375
▁diverse 9.75
▁groups 0.74365234375
, 0.767578125
▁the 0.460693359375
▁study 2.814453125
▁used 1.318359375
▁multiple 5.453125
▁log 0.72314453125
istic 0.042449951171875
▁regression 0.282958984375
▁analysis 1.2958984375
▁and 2.806640625
▁chose 8.5390625
▁medical 6.234375
▁mar 0.5087890625
iju 0.00958251953125
ana 0.0008015632629394531
▁as 0.54736328125
▁the 0.92236328125
▁contro 11.0859375
▁l 4.77734375
group 1.283203125
. 0.2880859375
<0x0A> 0.482666015625
This 4.2734375
▁type 6.17578125
▁of 0.00368499755859375
▁study 1.3720703125
▁is 1.328125
▁the 3.7890625
▁most 1.3349609375
▁reve 7.87109375
aling 0.005977630615234375
▁and 1.513671875
▁inclus 6.94921875
ive 0.0022373199462890625
, 3.060546875
▁as 1.2744140625
▁it 0.321044921875
▁contains 4.703125
▁direct 5.95703125
▁responses 5.7578125
▁from 0.60009765625
▁a 3.40234375
▁large 0.84326171875
▁number 0.44873046875
▁of 0.00485992431640625
▁participants 1.0224609375
. 0.64013671875
▁All 5.2734375
▁tools 8.0625
▁in 5.78515625
▁the 0.8544921875
▁form 4.2734375
▁of 0.0195465087890625
▁question 0.65478515625
na 0.0302276611328125
ires 0.003391265869140625
▁and 1.2001953125
▁scales 2.56640625
▁have 3.388671875
▁already 4.1640625
▁been 0.373779296875
▁used 2.333984375
▁and 1.7548828125
▁proved 2.275390625
▁their 1.3671875
▁effic 2.369140625
acy 0.023651123046875
▁for 3.599609375
▁collect 4.11328125
ing 0.005016326904296875
▁analyt 7.34375
ical 0.10723876953125
▁data 0.1689453125
. 0.353271484375
▁It 3.4453125
▁helps 4.3125
▁to 0.6552734375
▁system 6.80859375
at 0.51025390625
ize 0.01274871826171875
▁and 1.267578125
▁class 4.71875
ify 0.007137298583984375
▁distinct 8.3984375
▁kinds 6.2578125
▁of 0.015960693359375
▁information 2.220703125
▁for 4.0625
▁subsequent 5.05078125
▁un 8.625
comp 4.8515625
licated 0.03277587890625
▁services 12.46875
. 0.55224609375
▁Thus 4.8515625
, 0.00800323486328125
▁research 4.5234375
ers 0.289306640625
▁can 1.7099609375
▁compare 2.833984375
▁the 1.0068359375
▁effects 2.91015625
▁of 0.0953369140625
▁medic 3.724609375
ations 0.708984375
▁on 1.6904296875
▁patients 2.12890625
▁of 3.98828125
▁diverse 3.169921875
▁age 1.92578125
▁groups 2.2734375
, 0.70068359375
▁background 3.84765625
s 0.1300048828125
, 0.03143310546875
▁physical 5.54296875
▁conditions 1.2783203125
, 0.053863525390625
▁emot 6.35546875
ional 0.03594970703125
▁states 1.3046875
, 0.0640869140625
▁and 0.41455078125
▁so 2.537109375
▁on 0.1793212890625
. 0.06658935546875
<0x0A> 0.79248046875
The 0.765625
▁analysis 3.990234375
▁of 0.65087890625
▁any 9.484375
▁human 6.8359375
▁reaction 4.1953125
▁has 4.78515625
▁a 1.7939453125
▁high 3.16015625
▁potential 2.98046875
▁of 1.8583984375
▁subject 3.001953125
iveness 3.439453125
▁and 1.271484375
▁bias 1.896484375
, 2.060546875
▁especially 2.3828125
▁regarding 3.935546875
▁people 5.09765625
▁in 3.76953125
▁severe 2.646484375
▁pain 0.61669921875
▁and 2.25390625
▁un 5.58984375
stable 0.94873046875
▁emot 0.58837890625
ional 0.08221435546875
▁condition 2.396484375
. 0.050537109375
▁Perhaps 8.3984375
▁some 5.20703125
▁patients 2.0546875
▁tend 4.6953125
▁to 0.0110321044921875
▁ex 2.044921875
agger 0.0173492431640625
ate 0.0037593841552734375
▁their 0.9453125
▁de 3.150390625
press 2.005859375
ive 0.11236572265625
▁state 2.53515625
▁or 1.6201171875
▁vice 5.7109375
▁vers 0.037322998046875
a 0.0001239776611328125
, 1.109375
▁de 7.53515625
- 2.83984375
emph 0.408935546875
as 0.008575439453125
ize 0.07879638671875
▁serious 6.6953125
▁difficulties 5.62890625
. 0.849609375
▁Because 6.421875
▁the 2.71484375
▁survey 4.8203125
▁responses 6.97265625
▁were 1.466796875
▁thoroughly 8.703125
▁anonymous 2.791015625
, 0.274658203125
▁the 1.1953125
▁research 0.99755859375
ers 0.181640625
▁were 2.4140625
▁unable 2.953125
▁to 0.002086639404296875
▁carefully 7.73828125
▁analyze 2.783203125
▁each 2.412109375
▁patient 2.712890625
’ 0.57763671875
s 0.0018396377563476562
▁reaction 4.1171875
▁and 1.306640625
▁compare 3.6953125
▁it 0.8359375
▁to 0.6494140625
▁the 0.94921875
▁actual 4.3515625
▁states 7.6875
▁of 0.66015625
▁condition 6.94140625
. 0.337890625
▁More 6.296875
▁accurate 3.23828125
▁answers 4.41796875
▁could 1.8486328125
▁be 0.71826171875
▁obtained 1.03515625
▁by 1.45703125
▁professional 5.90625
▁psych 1.162109375
olog 0.38623046875
ists 0.004604339599609375
▁via 7.24609375
▁personal 2.537109375
▁communication 4.30859375
▁and 1.923828125
▁behavior 6.3515625
al 0.271240234375
▁an 9.796875
l 1.4287109375
ays 0.1263427734375
is 0.08453369140625
. 0.265625
▁However 2.82421875
, 0.0015439987182617188
▁this 1.40234375
▁method 2.333984375
▁of 2.68359375
▁research 1.84375
▁is 1.150390625
▁way 5.57421875
▁more 0.80078125
▁resource 4.75390625
- 0.28564453125
int 1.458984375
ensive 0.04473876953125
▁and 0.39453125
▁energy 10.5234375
- 0.08447265625
consum 0.362060546875
ing 0.007659912109375
. 0.681640625
<0x0A> 0.426513671875
Part 5.91796875
icip 0.1546630859375
ants 0.1448974609375
▁were 1.2900390625
▁rec 1.91015625
ru 0.004238128662109375
ited 0.00036978721618652344
▁for 1.68359375
▁six 0.331298828125
▁months 0.0101165771484375
▁at 0.330322265625
▁two 0.0758056640625
▁major 0.10040283203125
▁pain 0.040985107421875
▁relief 0.023590087890625
▁cent 0.01403045654296875
ers 0.003757476806640625
▁in 0.042938232421875
▁Israel 0.0162506103515625
. 0.1708984375
▁All 4.171875
▁patients 1.7578125
▁experienced 4.2265625
▁chron 0.859375
ic 0.0014581680297851562
▁pain 0.160888671875
▁for 2.53515625
▁at 0.640625
▁least 0.005096435546875
▁ 1.7255859375
3 1.515625
▁months 0.234375
. 1.21875
▁The 1.3837890625
▁study 1.673828125
▁included 1.6376953125
▁ 0.56494140625
8 2.986328125
9 2.501953125
0 2.9375
▁participants 1.634765625
, 1.412109375
▁of 2.75
▁which 0.431640625
▁ 0.089599609375
4 1.130859375
7 2.6640625
4 2.583984375
▁( 2.89453125
5 0.091064453125
9 4.953125
%) 0.7529296875
▁were 0.7724609375
▁treated 3.119140625
▁sole 6.8984375
ly 0.0014057159423828125
▁with 0.304443359375
▁op 1.1767578125
io 0.3427734375
ids 0.1614990234375
, 0.61572265625
▁ 0.81640625
3 1.232421875
2 2.24609375
9 2.4375
▁( 0.05047607421875
4 2.50390625
1 1.2939453125
%) 0.05645751953125
▁were 1.4453125
▁treated 0.517578125
▁with 0.37451171875
▁MM 0.8125
, 0.3916015625
▁and 0.1143798828125
▁ 0.1988525390625
7 1.9921875
7 2.35546875
▁( 0.12103271484375
8 1.873046875
. 0.96044921875
6 2.453125
%) 0.07354736328125
▁acquired 10.421875
▁both 0.6533203125
▁( 5.09375
Fe 9.40625
ing 1.1923828125
old 0.53173828125
▁et 1.0634765625
▁al 0.0269317626953125
., 0.1778564453125
▁ 0.018524169921875
2 0.00855255126953125
0 0.00043845176696777344
1 0.224853515625
7 1.646484375
). 0.05902099609375
▁The 1.224609375
▁remaining 7.484375
▁ten 6.89453125
▁participants 1.3427734375
▁who 4.83984375
▁did 2.193359375
▁not 0.00885009765625
▁receive 2.236328125
▁ph 3.759765625
arma 0.140625
ce 0.002300262451171875
ut 0.00016438961029052734
ical 0.005702972412109375
▁op 1.4052734375
io 0.06781005859375
ids 0.0244903564453125
▁and 2.55859375
▁medical 1.576171875
▁mar 0.239990234375
iju 0.00835418701171875
ana 0.0014829635620117188
▁were 0.406982421875
▁with 6.9921875
dra 0.06842041015625
wn 0.00022339820861816406
▁from 0.24072265625
▁the 0.18505859375
▁analysis 2.263671875
▁in 4.82421875
▁the 1.39453125
▁research 4.6015625
. 0.98486328125
▁Therefore 5.203125
, 0.01151275634765625
▁it 3.966796875
▁is 1.3564453125
▁not 3.095703125
▁possible 0.7001953125
▁to 0.006450653076171875
▁compreh 6.06640625
ens 0.08544921875
ively 0.0239105224609375
▁compare 1.1767578125
▁patients 5.17578125
▁taking 3.8671875
▁medic 4.15625
ations 0.5556640625
▁with 1.4931640625
▁those 1.029296875
▁who 0.76611328125
▁do 1.4521484375
▁not 0.007354736328125
. 0.58056640625
<0x0A> 0.587890625
The 0.86572265625
▁study 1.6708984375
▁conducted 4.19140625
▁a 1.751953125
▁correlation 6.5390625
▁type 9.40625
▁of 0.234130859375
▁research 0.97998046875
▁with 3.509765625
▁variable 8.46875
▁meas 7.09765625
ur 2.0390625
se 7.33203125
. 1.033203125
▁It 1.5654296875
▁evaluated 4.54296875
▁the 0.58935546875
▁inter 6.12109375
dep 2.5234375
end 0.0242919921875
ence 0.015655517578125
▁of 0.6728515625
▁various 3.650390625
▁factors 0.8857421875
▁that 2.94921875
▁affected 4.0
▁the 0.492431640625
▁physical 6.203125
▁and 0.258056640625
▁emot 0.354736328125
ional 0.001224517822265625
▁condition 1.47265625
▁of 0.037628173828125
▁patients 0.775390625
▁experien 2.8515625
cing 0.0012254714965820312
▁chron 0.2149658203125
ic 0.0027103424072265625
▁pain 0.015380859375
. 0.1275634765625
▁For 4.21875
▁example 1.232421875
, 0.001911163330078125
▁the 1.013671875
▁survey 5.40625
▁showed 4.0625
▁that 0.4501953125
▁the 1.8681640625
▁ratio 6.734375
▁of 0.08544921875
▁female 3.744140625
▁patients 1.02734375
▁was 1.25390625
▁remark 8.03125
ably 0.006557464599609375
▁higher 0.18310546875
▁in 2.439453125
▁the 0.46142578125
▁op 3.65234375
i 3.064453125
ates 0.036712646484375
▁group 0.21240234375
▁compared 2.6328125
▁to 0.0416259765625
▁the 0.615234375
▁MM 0.137451171875
▁group 0.283447265625
. 0.5419921875
▁In 3.396484375
▁turn 4.0
, 0.002101898193359375
▁people 4.98828125
▁on 4.78125
▁op 2.994140625
i 0.66748046875
ates 0.01023101806640625
▁were 0.89208984375
▁more 1.3818359375
▁likely 0.285400390625
▁to 0.0225982666015625
▁report 2.83203125
▁major 5.9296875
▁de 0.460205078125
press 0.69775390625
ive 0.00740814208984375
▁dis 0.99169921875
orders 1.5322265625
. 1.642578125
<0x0A> 2.177734375
The 0.91650390625
▁question 5.484375
na 0.7578125
ires 0.0034923553466796875
▁used 1.97265625
▁different 7.78125
▁variable 8.2265625
▁measures 2.154296875
▁to 1.908203125
▁collect 2.49609375
▁information 1.6484375
. 1.2353515625
▁For 1.5478515625
▁example 0.281982421875
, 0.0016222000122070312
▁it 4.19921875
▁included 1.9775390625
▁compreh 8.6328125
ensive 0.053192138671875
▁so 5.70703125
cio 0.0015735626220703125
- 0.309326171875
dem 0.1246337890625
ographic 0.1107177734375
▁data 0.84423828125
: 4.984375
▁gen 9.9375
de 1.2822265625
, 0.5615234375
r 8.1015625
▁age 0.347900390625
, 0.0231170654296875
▁country 4.23046875
, 2.34375
▁type 4.37890625
▁of 0.07598876953125
▁residence 4.15234375
▁( 2.484375
urban 0.8154296875
/ 1.3203125
r 0.1697998046875
ural 0.01007080078125
), 0.2052001953125
▁years 6.16015625
▁of 0.1832275390625
▁education 0.57275390625
, 0.11541748046875
▁and 1.36328125
▁employ 2.5
ment 0.007328033447265625
▁status 0.69091796875
. 0.1614990234375
▁Pat 4.62109375
ients 0.08154296875
▁were 1.099609375
▁also 0.80224609375
▁asked 0.52001953125
▁about 1.0234375
▁their 0.65576171875
▁medical 2.49609375
▁history 0.60498046875
▁over 8.6328125
▁the 0.06884765625
▁years 4.8046875
▁and 1.7138671875
▁the 1.498046875
▁current 2.955078125
▁presence 4.84765625
▁of 0.08636474609375
▁any 2.326171875
▁severe 3.84375
▁dise 1.947265625
ases 0.0024394989013671875
▁such 4.4453125
▁as 0.00441741943359375
▁heart 2.609375
▁failure 1.685546875
, 0.298828125
▁di 1.587890625
ab 0.00399017333984375
etes 0.0022525787353515625
, 0.0694580078125
▁ar 4.015625
th 0.1016845703125
rit 0.05120849609375
is 0.0130615234375
, 0.035308837890625
▁and 1.2197265625
▁so 0.75830078125
▁on 0.0479736328125
. 0.04815673828125
▁The 1.7236328125
▁third 6.796875
▁measure 3.75
▁of 2.341796875
▁the 0.6904296875
▁question 1.796875
naire 0.42138671875
▁was 1.0380859375
▁indicated 10.578125
▁by 1.2373046875
▁information 6.96484375
▁on 2.0234375
▁any 5.56640625
▁twelve 14.0859375
- 0.202392578125
month 0.1251220703125
▁and 4.98828125
▁lifetime 0.603515625
▁drug 3.49609375
▁and 1.7001953125
▁alco 0.1280517578125
hol 0.002483367919921875
▁consumption 4.6640625
▁. 8.9921875
In 5.6484375
▁addition 1.0498046875
, 0.21923828125
▁the 0.88818359375
▁record 10.3984375
▁included 1.173828125
▁a 2.7265625
▁pain 4.5390625
▁measurement 5.01171875
▁scale 0.8017578125
▁from 4.45703125
▁ 0.49658203125
0 0.28955078125
▁to 0.26318359375
▁ 0.016082763671875
1 0.07586669921875
0 0.03955078125
▁to 3.142578125
▁evaluate 1.48828125
▁dis 6.12890625
com 0.15673828125
fort 0.008148193359375
▁feelings 8.296875
▁during 4.09375
▁the 0.2822265625
▁last 1.0966796875
▁month 1.732421875
. 0.254150390625
<0x0A> 0.5322265625
Am 6.0546875
ong 0.0311126708984375
▁all 2.296875
▁participants 2.25
▁in 3.669921875
▁the 0.1697998046875
▁study 0.50048828125
, 0.04901123046875
▁ 0.8486328125
4 1.7958984375
2 2.490234375
. 1.1064453125
2 2.22265625
% 0.06427001953125
▁suffered 3.662109375
▁from 0.049957275390625
▁de 1.583984375
pression 0.2568359375
, 0.96826171875
▁and 1.34765625
▁ 0.130615234375
3 1.4619140625
7 2.390625
% 2.541015625
▁experienced 2.048828125
▁excess 6.87890625
ive 0.0316162109375
▁anx 0.218505859375
iety 0.005115509033203125
. 0.367919921875
▁The 1.41015625
▁pl 10.7578125
ur 0.5634765625
ality 0.0016145706176757812
▁of 0.105712890625
▁de 2.431640625
press 1.291015625
ive 0.0557861328125
▁dis 2.736328125
orders 0.09136962890625
▁among 3.119140625
▁p 8.4453125
ate 1.974609375
ints 0.201171875
▁in 2.6484375
▁the 0.31005859375
▁op 0.437255859375
i 0.399169921875
ates 0.005359649658203125
, 8.9453125
▁medical 4.28515625
▁mar 0.082275390625
iju 0.01471710205078125
ana 0.0032176971435546875
, 0.27490234375
▁and 0.0950927734375
▁mixed 1.8271484375
▁OP 11.2734375
MM 4.63671875
▁groups 0.5439453125
▁number 8.75
ed 0.032745361328125
▁ 0.1705322265625
5 1.7646484375
7 2.693359375
. 0.55810546875
1 2.5078125
%, 0.2152099609375
▁ 0.0086669921875
2 2.19921875
2 2.630859375
. 0.10601806640625
3 2.265625
%, 0.07861328125
▁and 0.060699462890625
▁ 0.0030422210693359375
5 2.01171875
1 2.064453125
. 0.159423828125
4 1.94140625
%, 0.232666015625
▁respectively 0.044158935546875
. 0.2196044921875
▁The 1.2841796875
▁pl 3.99609375
ur 0.0225982666015625
ality 0.0009064674377441406
▁of 0.026214599609375
▁anx 0.457275390625
iety 0.037353515625
▁contained 10.7578125
▁ 0.22216796875
4 1.1318359375
8 2.353515625
. 0.1796875
4 2.177734375
% 1.869140625
▁among 2.658203125
▁OP 5.46875
▁patients 6.18359375
, 0.277099609375
▁ 0.08209228515625
2 0.9619140625
1 2.48828125
. 0.11358642578125
5 2.125
% 0.0279998779296875
▁among 0.423828125
▁MM 0.10528564453125
▁patients 0.34521484375
, 0.0261077880859375
▁and 0.0178375244140625
▁ 0.0236053466796875
3 1.373046875
8 1.8984375
. 0.134765625
7 2.201171875
% 0.01849365234375
▁among 0.1990966796875
▁OP 2.083984375
MM 0.1497802734375
▁participants 2.859375
. 0.203857421875
▁Pat 5.1875
ients 0.0200042724609375
▁who 1.943359375
▁took 2.29296875
▁strong 10.0234375
▁op 0.626953125
i 0.8154296875
ates 0.0140838623046875
▁were 1.1796875
▁t 9.515625
ended 0.95458984375
▁to 0.009765625
▁place 9.7890625
▁their 2.02734375
▁pain 1.1953125
▁on 1.9091796875
▁a 0.57568359375
▁scale 1.810546875
▁of 0.4130859375
▁ 0.09796142578125
9 2.484375
▁to 2.267578125
▁ 0.018402099609375
1 0.00655364990234375
0 0.00821685791015625
▁F 13.0859375
( 5.00390625
eing 13.796875
old 0.0234832763671875
▁et 0.1435546875
▁al 0.0228271484375
., 0.10693359375
▁ 0.042877197265625
2 0.004383087158203125
0 0.00113677978515625
1 0.00505828857421875
7 0.025360107421875
). 0.071044921875
▁They 4.46484375
▁were 1.6865234375
▁also 0.9189453125
▁an 9.40625
gu 3.373046875
ished 0.0980224609375
▁em 5.97265625
otion 0.006725311279296875
ally 0.00600433349609375
▁and 1.1298828125
▁react 7.47265625
ed 0.0287628173828125
▁rad 9.125
ically 0.0129852294921875
▁neg 4.78125
atively 0.022918701171875
▁to 0.2008056640625
▁almost 5.55078125
▁all 1.5322265625
▁survey 3.775390625
▁questions 0.2457275390625
. 0.344970703125
▁Pat 3.62890625
ients 0.00775146484375
▁who 1.26953125
▁took 1.681640625
▁only 4.3359375
▁MM 0.371337890625
▁or 2.767578125
▁mixed 2.57421875
▁medic 1.3466796875
ations 0.27392578125
▁course 13.4609375
▁had 2.6484375
▁a 1.390625
▁significantly 2.888671875
▁more 3.201171875
▁stable 2.3984375
▁emot 0.798828125
ional 0.00397491455078125
▁state 0.6376953125
▁and 1.0595703125
▁cop 6.6484375
ed 0.0201873779296875
▁with 0.35205078125
▁pain 0.837890625
▁more 1.796875
▁manage 7.11328125
able 1.59765625
. 0.32177734375
<0x0A> 0.335205078125
One 5.1328125
▁of 0.2135009765625
▁the 0.0053863525390625
▁major 2.52734375
▁limitations 2.390625
▁is 2.958984375
▁the 0.476318359375
▁ins 4.66796875
u 0.0823974609375
fficient 0.1478271484375
ly 3.423828125
▁high 3.12890625
▁response 3.365234375
▁rate 0.1063232421875
, 2.630859375
▁ 4.48046875
5 1.716796875
7 2.81640625
% 2.142578125
▁instead 6.296875
▁of 0.0076141357421875
▁ 0.45703125
7 1.9423828125
0 0.427490234375
% 1.3544921875
▁( 2.494140625
Fe 0.93212890625
ing 0.014251708984375
old 0.00592041015625
▁et 0.02374267578125
▁al 0.005504608154296875
., 0.0244903564453125
▁ 0.009857177734375
2 0.000545501708984375
0 0.0005850791931152344
1 0.0022907257080078125
7 0.005611419677734375
). 0.016876220703125
▁It 1.830078125
▁can 3.0859375
▁be 0.7216796875
▁fairly 8.40625
▁explained 1.5537109375
▁by 0.19970703125
▁the 0.273681640625
▁weak 7.421875
▁focus 7.03515625
▁of 0.70556640625
▁respond 5.67578125
ents 0.13232421875
▁who 3.41015625
▁have 3.88671875
▁overcome 8.1484375
▁severe 2.134765625
▁pain 0.5166015625
▁sens 7.6640625
ations 0.30712890625
▁and 0.87890625
▁de 4.89453125
press 1.048828125
ive 0.06304931640625
▁episodes 2.25390625
. 0.501953125
▁It 2.802734375
▁is 0.7685546875
▁not 2.578125
▁clear 3.52734375
▁how 1.896484375
▁to 3.482421875
▁use 5.16015625
▁these 2.806640625
▁statistics 3.875
, 3.072265625
▁as 0.66845703125
▁they 1.8798828125
▁still 5.16015625
▁may 4.6640625
▁be 1.296875
▁relevant 5.984375
▁for 1.64453125
▁the 1.896484375
▁overall 4.6875
▁analysis 2.62890625
. 0.923828125
